02151nas a2200277   4500000000100000008004100001260001200042653001200054653001600066653001100082653001300093653000800106100002900114700002400143700002300167700002600190700002800216700003000244700002600274245013100300300001200431490000700443520139500450022001401845020001401859       2021                            d  c10/202110aAnxiety10aReliability10aHealth10aValidity10aHIV1 aTomás Caycho-Rodríguez1 aJosé Ventura-León1 aMario Reyes-Bossio1 aMartín Noé-Grijalva1 aMiguel Barboza-Palomino1 aBrian Norman Peña-Calero1 aCarlos Carbajal-León00aPreliminary evidence of the validity and reliability of a brief measure of the impact of anxiety on the health of HIV patients  a123-1310 v273 aBackground and Objectives: It is common to use measures that do not directly assess the impact of anxiety on the health of people with HIV. The objective of the study was to evaluate the evidence of validity and reliability of the Spanish version of the Health-Related Anxiety Scale (HRAS).

Materials and Methods: 100 patients diagnosed with HIV participated, selected by convenience sampling (76.5% men and 24.4% women; Average age = 39.96 years, SD = 13.19). The factorial structure of the HRAS was evaluated from the Confirmatory Factor Analysis (CFA). Likewise, the latent-level relationships of HRAS with life satisfaction, generalized anxiety, and depression were evaluated using a structural equation model. Reliability was assessed with McDonald's omega coefficient.

Results: The one-dimensional structure of the HRAS fitted adequately (χ2 = 2.74, p = .254; CFI = .997; TLI = .992; RMSEA = .092 [IC90%: .000, .328] and SRMR = .036) and high reliability (ω = .94). The model that related the latent variables had a good fit (χ2 = 58.11, p = .51, RMSEA = .05 90% CI [.00-.09], CFI = .99, SRMR = .03) , and indicated that HRAS was correlated with satisfaction with life (p = -.52; p <0.01), depression (p = .57; p <0.01) and generalized anxiety (p = .84; p <0.01).

Conclusion: HRAS a valid and reliable measure to assess the impact of anxiety on the health of HIV patients.  a1134-7937  a2174-0437